Cellular mechanisms of opioid tolerance: studies in single brain neurons

MJ Christie, JT Williams and RA North

Vollum Institute, Oregon Health Sciences University, Portland 97201.

Intracellular recordings of membrane potassium current were made from rat locus coeruleus in vitro. The effects of agonists at mu-opioid receptors were studied on neurons from rats that had been chronically treated with morphine; these were compared with actions on neurons from control rats. Tolerance to the opioid-induced increase in potassium conductance was observed, and this was more pronounced for normorphine than for [Met5]enkephalin and [D-Ala2, Mephe4, Gly5-ol]enkephalin: experiments with the irreversible receptor blocker beta- chlornaltrexamine indicated that normorphine had lower intrinsic efficacy than [Met5]enkephalin and [D-Ala2 MePhe4, Gly5-ol]enkephalin. This adaptation was not due to any change of the properties of the potassium conductance activated by mu-receptors because both full and partial agonists at alpha 2-adrenoceptors, which couple to the same potassium conductance, were unchanged in their effectiveness; nor was it associated with any change in the affinity of mu-receptors for the antagonist naloxone. Naloxone had no effect on the neurons other than simple competitive reversal of the action of the mu-receptor agonists. These results demonstrate that 1) the mechanism responsible for tolerance in locus coeruleus neurons is specifically associated with mu- receptors and/or their coupling to potassium channels, 2) the intrinsic efficacy of an opioid determines the degree of tolerance observed, and 3) tolerance and physical dependence can be dissociated at the cellular level.

Volume 32, Issue 5, pp. 633-638, 11/01/1987
Copyright © 1987 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				S. Arttamangkul, N. Quillinan, M. J. Low, M. von Zastrow, J. Pintar, and J. T. Williams Differential Activation and Trafficking of {micro}-Opioid Receptors in Brain Slices Mol. Pharmacol., October 1, 2008; 74(4): 972 - 979. [Abstract] [Full Text] [PDF]

				M. Vosoughian, A. Dabbagh, S. Rajaei, and H. Maftuh The Duration of Spinal Anesthesia with 5% Lidocaine in Chronic Opium Abusers Compared with Nonabusers Anesth. Analg., August 1, 2007; 105(2): 531 - 533. [Abstract] [Full Text] [PDF]

				V. C. Dang and J. T. Williams Morphine-Induced {micro}-Opioid Receptor Desensitization Mol. Pharmacol., October 1, 2005; 68(4): 1127 - 1132. [Abstract] [Full Text] [PDF]

				C. P. Bailey, E. Kelly, and G. Henderson Protein Kinase C Activation Enhances Morphine-Induced Rapid Desensitization of {micro}-Opioid Receptors in Mature Rat Locus Ceruleus Neurons Mol. Pharmacol., December 1, 2004; 66(6): 1592 - 1598. [Abstract] [Full Text] [PDF]

				E. C. Dumont and J. T. Williams Noradrenaline Triggers GABAA Inhibition of Bed Nucleus of the Stria Terminalis Neurons Projecting to the Ventral Tegmental Area J. Neurosci., September 22, 2004; 24(38): 8198 - 8204. [Abstract] [Full Text] [PDF]

				V. C. Dang and J. T. Williams Chronic Morphine Treatment Reduces Recovery from Opioid Desensitization J. Neurosci., September 1, 2004; 24(35): 7699 - 7706. [Abstract] [Full Text] [PDF]

				J. A. Deleo, F. Y. Tanga, and V. L. Tawfik Neuroimmune Activation and Neuroinflammation in Chronic Pain and Opioid Tolerance/Hyperalgesia Neuroscientist, February 1, 2004; 10(1): 40 - 52. [Abstract] [PDF]

				S. L. Borgland, M. Connor, P. B. Osborne, J. B. Furness, and M. J. Christie Opioid Agonists Have Different Efficacy Profiles for G Protein Activation, Rapid Desensitization, and Endocytosis of Mu-opioid Receptors J. Biol. Chem., May 23, 2003; 278(21): 18776 - 18784. [Abstract] [Full Text] [PDF]

				C. Blanchet and C. Luscher Desensitization of {micro}-opioid receptor-evoked potassium currents: Initiation at the receptor, expression at the effector PNAS, March 21, 2002; (2002) 72075399. [Abstract] [Full Text] [PDF]

				J. P. Wetherington and N. A. Lambert Differential Desensitization of Responses Mediated by Presynaptic and Postsynaptic A1 Adenosine Receptors J. Neurosci., February 15, 2002; 22(4): 1248 - 1255. [Abstract] [Full Text] [PDF]

				A. Ivanov and G. Aston-Jones Local Opiate Withdrawal in Locus Coeruleus Neurons In Vitro J Neurophysiol, June 1, 2001; 85(6): 2388 - 2397. [Abstract] [Full Text] [PDF]

				J. T. Williams, M. J. Christie, and O. Manzoni Cellular and Synaptic Adaptations Mediating Opioid Dependence Physiol Rev, January 1, 2001; 81(1): 299 - 343. [Abstract] [Full Text] [PDF]

				X. Chen, H. G. Marrero, R. Murphy, Y.-J. Lin, and J. E. Freedman Altered gating of opiate receptor-modulated K+ channels on amygdala neurons of morphine-dependent rats PNAS, December 19, 2000; 97(26): 14692 - 14696. [Abstract] [Full Text] [PDF]

				E. J. Van Bockstaele, J. Peoples, A. S. Menko, K. McHugh, and G. Drolet Decreases in Endogenous Opioid Peptides in the Rat Medullo-Coerulear Pathway after Chronic Morphine Treatment J. Neurosci., December 1, 2000; 20(23): 8659 - 8666. [Abstract] [Full Text] [PDF]

				L. J. Sim-Selley, D. E. Selley, L. J. Vogt, S. R. Childers, and T. J. Martin Chronic Heroin Self-Administration Desensitizes {micro} Opioid Receptor-Activated G-Proteins in Specific Regions of Rat Brain J. Neurosci., June 15, 2000; 20(12): 4555 - 4562. [Abstract] [Full Text] [PDF]

				Y. Shoji, J. Delfs, and J. T. Williams Presynaptic Inhibition of GABAB-Mediated Synaptic Potentials in the Ventral Tegmental Area during Morphine Withdrawal J. Neurosci., March 15, 1999; 19(6): 2347 - 2355. [Abstract] [Full Text] [PDF]

				C. Ledent, O. Valverde, G. Cossu, F. Petitet, J. Aubert, F. Beslot, G. A. Böhme, A. Imperato, T. Pedrazzini, B. P. Roques, et al. Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB1 Receptor Knockout Mice Science, January 15, 1999; 283(5400): 401 - 404. [Abstract] [Full Text]

				S. L. Ingram, C. W. Vaughan, E. E. Bagley, M. Connor, and M. J. Christie Enhanced Opioid Efficacy in Opioid Dependence Is Caused by an Altered Signal Transduction Pathway J. Neurosci., December 15, 1998; 18(24): 10269 - 10276. [Abstract] [Full Text] [PDF]

				A. Kovoor, J. P. Celver, A. Wu, and C. Chavkin Agonist Induced Homologous Desensitization of µ-Opioid Receptors Mediated by G Protein-Coupled Receptor Kinases Is Dependent on Agonist Efficacy Mol. Pharmacol., October 1, 1998; 54(4): 704 - 711. [Abstract] [Full Text]

				E. J. Wagner, O. K. Ronnekleiv, and M. J. Kelly Protein Kinase A Maintains Cellular Tolerance to Mu Opioid Receptor Agonists in Hypothalamic Neurosecretory Cells with Chronic Morphine Treatment: Convergence on a Common Pathway with Estrogen in Modulating Mu Opioid Receptor/Effector Coupling J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1266 - 1273. [Abstract] [Full Text] [PDF]

				A. Kovoor, V. Nappey, B. L. Kieffer, and C. Chavkin µ and delta  Opioid Receptors Are Differentially Desensitized by the Coexpression of beta -Adrenergic Receptor Kinase 2 and beta -Arrestin 2 in Xenopus Oocytes J. Biol. Chem., October 31, 1997; 272(44): 27605 - 27611. [Abstract] [Full Text] [PDF]

				S. Ingram, T. J. Wilding, E. W. McCleskey, and J. T. Williams Efficacy and Kinetics of Opioid Action on Acutely Dissociated Neurons Mol. Pharmacol., July 1, 1997; 52(1): 136 - 143. [Abstract] [Full Text]

				A. H. Lagrange, O. K. Rønnekleiv, and M. J. Kelly Modulation of G Protein-Coupled Receptors by an Estrogen Receptor that Activates Protein Kinase A Mol. Pharmacol., April 1, 1997; 51(4): 605 - 612. [Abstract] [Full Text]

				E. J. Wagner, G. Zhang, A. H. Lagrange, O. K. Rønnekleiv, and M. J. Kelly Tolerance to µ-Opioid Receptor Agonists but not Cross-tolerance to gamma -Aminobutyric AcidB Receptor Agonists in Arcuate A12 Dopamine Neurons with Chronic Morphine Treatment J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 1057 - 1064. [Abstract] [Full Text]

				A. Bonci and J. T. Williams Increased Probability of GABA Release during Withdrawal from Morphine J. Neurosci., January 15, 1997; 17(2): 796 - 803. [Abstract] [Full Text] [PDF]

				C. J. Malanga, J. Meng, W. W. Fleming, and D. A. Taylor Chronic Morphine Treatment of Guinea Pigs Induces Nonspecific Sensitivity Changes in the Nucleus Tractus Solitarius In Vitro J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 16 - 23. [Abstract] [Full Text]

				D. E. Selley, L. J. Sim, R. Xiao, Q. Liu, and S. R. Childers {micro}-Opioid Receptor-Stimulated Guanosine-5'-O-(gamma -thio)-triphosphate Binding in Rat Thalamus and Cultured Cell Lines: Signal Transduction Mechanisms Underlying Agonist Efficacy Mol. Pharmacol., January 1, 1997; 51(1): 87 - 96. [Abstract] [Full Text]

				B. Chieng and M. J. Christie Local Opioid Withdrawal in Rat Single Periaqueductal Gray Neurons In Vitro J. Neurosci., November 15, 1996; 16(22): 7128 - 7136. [Abstract] [Full Text] [PDF]

				K. Trujillo and H Akil Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801 Science, January 4, 1991; 251(4989): 85 - 87. [Abstract] [PDF]

				G. Koob and F. Bloom Cellular and molecular mechanisms of drug dependence Science, November 4, 1988; 242(4879): 715 - 723. [Abstract] [PDF]

				J. P. Celver, J. Lowe, A. Kovoor, V. V. Gurevich, and C. Chavkin Threonine 180 Is Required for G-protein-coupled Receptor Kinase 3- and beta -Arrestin 2-mediated Desensitization of the {micro}-Opioid Receptor in Xenopus Oocytes J. Biol. Chem., February 9, 2001; 276(7): 4894 - 4900. [Abstract] [Full Text] [PDF]

				C. Blanchet and C. Luscher Desensitization of {micro}-opioid receptor-evoked potassium currents: Initiation at the receptor, expression at the effector PNAS, April 2, 2002; 99(7): 4674 - 4679. [Abstract] [Full Text] [PDF]